Medicare Enrolled
Dr. Joel Alcid, M.D.
Internal Medicine · Rutherford, NJ
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Alcid from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Alcid?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Alcid
Dr. Joel Alcid is an internal medicine specialist in Rutherford, NJ, with 16 years of NPI registration. Based on federal Medicare data, Dr. Alcid performed 1,145 Medicare services across 520 unique beneficiaries.
Between the years covered by Open Payments, Dr. Alcid received a total of $3,918 from 57 pharmaceutical and/or device companies across 158 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in internal medicine. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Alcid is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 16 years in practice
▲ Top 41% volume in NJ
$3,918 industry payments
Medicare Practice Summary
Medicare Utilization ↗1,145
Medicare services
Top 41% in NJ for internal medicine
520
Unique beneficiaries
$44
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~72 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Blood draw (venipuncture) Insertion of a needle into a vein to collect a blood sample. |
246 | $8 | $32 |
| Complete blood count (CBC) with differential An automated laboratory test that measures the levels of red blood cells, white blood cells, and platelets in the blood, including a breakdown of the different types of white blood cells. |
239 | $8 | $23 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
221 | $102 | $421 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
129 | $12 | $48 |
| Vitamin B-12 injection An injection of vitamin B-12 (cyanocobalamin) with a dose of up to 1000 mcg. |
73 | $1 | $6 |
| Hospital follow-up visit, high complexity Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter. |
63 | $102 | $380 |
| Intravenous infusion, 1 hour or less Administration of medication or fluid directly into a vein for therapeutic, preventive, or diagnostic purposes. The procedure lasts one hour or less. |
41 | $59 | $224 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
33 | $68 | $299 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
27 | $148 | $553 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
26 | $136 | $544 |
| Intravenous chemotherapy infusion, 1 hour or less Administration of chemotherapy medication directly into a vein. The procedure takes one hour or less to complete. |
25 | $112 | $457 |
| Additional sequential IV infusion, 1 hour or less This code represents an additional intravenous infusion administered sequentially to a primary infusion. It covers the administration time of one hour or less. |
22 | $25 | $100 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
7.7% high complexity
17.6% medium
74.7% routine
Industry Payment Transparency
Open Payments through 2024 ↗$3,918
Total received (2018-2024)
Avg $560/year across 7 years
Top 18% in NJ for internal medicine
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
57
Companies
158
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$3,424 (87.4%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$494 (12.6%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$600
2023
$949
2022
$115
2021
$373
2020
$586
2019
$1,280
2018
$15
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Adaptive Biotechnologies Corporation
$64
Merck Sharp & Dohme LLC
$39
PFIZER INC.
$35
Janssen Biotech, Inc.
$33
Mirati Therapeutics, Inc.
$30
Pharmacosmos Therapeutics Inc.
$23
TAIHO ONCOLOGY, INC.
$23
Novartis Pharmaceuticals Corporation
$23
Dendreon Pharmaceuticals LLC
$22
Apellis Pharmaceuticals, Inc.
$22
BeiGene USA, Inc.
$21
Astellas Pharma US Inc
$21
Takeda Pharmaceuticals U.S.A., Inc.
$20
Bayer Healthcare Pharmaceuticals Inc.
$19
Regeneron Healthcare Solutions, Inc.
$18
GlaxoSmithKline, LLC.
$18
AstraZeneca Pharmaceuticals LP
$18
Lilly USA, LLC
$18
Blueprint Medicines Corporation
$18
Azurity Pharmaceuticals, Inc.
$17
Stemline Therapeutics Inc.
$17
Daiichi Sankyo Inc.
$17
Octapharma USA, Inc.
$17
Incyte Corporation
$17
JAZZ PHARMACEUTICALS INC.
$16
Alnylam Pharmaceuticals Inc.
$14
Top 3 companies account for 23.0% of 2024 payments
All-time payments by company (2018-2024) ›
Janssen Biotech, Inc.
$387
Celgene Corporation
$306
PFIZER INC.
$262
AstraZeneca Pharmaceuticals LP
$231
Astellas Pharma US Inc
$206
Lilly USA, LLC
$177
Amgen Inc.
$160
Novartis Pharmaceuticals Corporation
$150
JAZZ PHARMACEUTICALS INC.
$129
E.R. Squibb & Sons, L.L.C.
$125
Epizyme, Inc.,
$125
Progenics Pharmaceuticals, Inc.
$123
Kite Pharma, Inc.
$100
Takeda Pharmaceuticals U.S.A., Inc.
$73
Merck Sharp & Dohme Corporation
$71
Bayer Healthcare Pharmaceuticals Inc.
$71
Daiichi Sankyo Inc.
$69
Adaptive Biotechnologies Corporation
$64
Boehringer Ingelheim Pharmaceuticals, Inc.
$62
Merck Sharp & Dohme LLC
$59
Alexion Pharmaceuticals, Inc.
$54
GlaxoSmithKline, LLC.
$51
Dendreon Pharmaceuticals LLC
$49
Pharmacosmos Therapeutics Inc.
$48
Incyte Corporation
$48
EMD Serono, Inc.
$44
Blueprint Medicines Corporation
$39
Eisai Inc.
$36
Agios Pharmaceuticals, Inc.
$34
Shire North American Group Inc
$32
Genentech USA, Inc.
$30
Mirati Therapeutics, Inc.
$30
Pharmacyclics LLC, An AbbVie Company
$29
Lexicon Pharmaceuticals, Inc.
$28
EISAI INC.
$27
Emmaus Medical, Inc.
$27
Gilead Sciences, Inc.
$26
BTG International, Inc.
$25
TAIHO ONCOLOGY, INC.
$23
Apellis Pharmaceuticals, Inc.
$22
BeiGene USA, Inc.
$21
Coherus Biosciences Inc.
$20
Regeneron Healthcare Solutions, Inc.
$18
GENZYME CORPORATION
$18
Janssen Pharmaceuticals, Inc
$18
ADC Therapeutics America, Inc.
$18
Azurity Pharmaceuticals, Inc.
$17
Stemline Therapeutics Inc.
$17
Ipsen Biopharmaceuticals, Inc
$17
Octapharma USA, Inc.
$17
Alnylam Pharmaceuticals Inc.
$14
Seattle Genetics, Inc.
$14
Seagen Inc.
$14
Karyopharm Therapeutics Inc.
$13
AbbVie Inc.
$13
Kyowa Kirin, Inc.
$11
Secura Bio, Inc.
$10
Top 3 companies account for 24.4% of all-time payments
Associated products mentioned in payments ›
ADYNOVATE · ALIMTA · ALUNBRIG · AYVAKIT · Abraxane · BAVENCIO · BRAFTOVI · BRUKINSA · Bavencio · Blincyto · COSELA · CYRAMZA · ELIQUIS · ELITEK · ERLEADA · Empaveli · Endari · Enhertu · Fabhalta · Farydak · GILOTRIF · GIVLAARI · IBRANCE · IMBRUVICA · IMFINZI · INJECTAFER · INREBIC · Imbruvica · JAKAFI · JAYPIRCA · JEMPERLI · KEYTRUDA · KISQALI · KRAZATI · Kyprolis · LIBTAYO · LONSURF · LUMAKRAS · LYNPARZA · Lenvima · MONOFERRIC · NINLARO · Nubeqa · OCTAGAM IMMUNE GLOBULIN (HUMAN) · ONUREG · OPDIVO · Onivyde · Orserdu · PADCEV · PIQRAY · POTELIGEO · PROMACTA · PROVENGE · PYLARIFY · Padcev · REBLOZYL · Revlimid · Stivarga · TAGRISSO · TASIGNA · TAZVERIK · TECVAYLI · TIBSOVO · Tecentriq · Trodelvy · ULTOMIRIS · Udenyca · Ultomiris · VENCLEXTA · VERZENIO · VIVIMUSTA · VONVENDI · VORAXAZE · VYXEOS · XALKORI · XARELTO · XOSPATA · XPOVIO · XTANDI · Xermelo · Xospata · Xtandi · Yescarta · ZEJULA · ZEPZELCA · clonoSEQ
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (87%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
Internal medicine physicians within 10 mi
10,866
Per 100K population
1138.1
County median income
$123,715
Nearest hospital
ST MARY'S GENERAL HOSPITAL
2.8 mi
2.8 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Alcid is a clinical cardiology specialist, with moderate Medicare volume, with low-engagement industry engagement in the top 18% of NJ peers, with 16 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Alcid experienced with blood draw (venipuncture)?
Based on Medicare claims data, Dr. Alcid performed 246 blood draw (venipuncture) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Alcid receive payments from pharmaceutical companies?
Yes. Dr. Alcid received a total of $3,918 from 57 companies across 158 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Alcid's costs compare to other internal medicine physicians in Rutherford?
Dr. Alcid's average Medicare payment per service is $44. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Alcid) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Internal Medicine Physicians in Rutherford
Browse internal medicine physicians in Rutherford ranked by procedure volume and transparency data.
Highest volume
Top Internal Medicine Physicians in NJ
Internal medicine physicians ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Internal Medicine Physicians in NJ
Which NJ internal medicine physicians receive the most from drug and device companies.
By company
Janssen Biotech, Inc. Payments to Doctors
See all physicians who received payments from Janssen Biotech, Inc.
By company
Celgene Corporation Payments to Doctors
See all physicians who received payments from Celgene Corporation.
By company
PFIZER INC. Payments to Doctors
See all physicians who received payments from PFIZER INC.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology